MIRA INFORM REPORT
|
Report Date : |
22.12.2011 |
IDENTIFICATION DETAILS
|
Name : |
TRANSO - PHARM HANDELS |
|
|
|
|
Registered Office : |
Bultek 5, Siek, 22962 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
29.10.1987 |
|
|
|
|
Com. Reg. No.: |
4750AH |
|
|
|
|
Legal Form : |
Private Subsidiary Company |
|
|
|
|
Line of Business : |
wholesale of industrial chemicals |
|
|
|
|
No. of Employees
: |
25 persons |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Small Company |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Germany |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
TRANSO - PHARM
HANDELS - GMBH
Bultek 5
Siek, 22962
Germany
Tel: +49 (0) 4107 87780
Fax: +49 (0) 4107 8778100
Synthesis
Employees: 25
Company Type: Private
Subsidiary
Corporate Family: 3
Companies
Ultimate Parent: Transo-Pharm
Holding-AG
Incorporation Date:
29-Oct-1987
Financials in: USD
(Millions)
Fiscal Year End:
31-Dec-2009
Reporting Currency: Euro
Annual Sales: 16.5
Total Assets: 7.1
Business Description
TRANSO - PHARM
HANDELS - GMBH is primarily engaged in wholesale of industrial chemicals
(aniline, printing ink, essential oils, industrial gases, chemical glues, colouring
matter, synthetic resin, methanol, paraffin, scents and flavourings, soda,
industrial salt, acids and sulphur, starch derivatives, etc.); wholesale of
fertilisers and agro-chemical products; wholesale of plastic materials in
primary forms; and wholesale of rubber.
Industry
Industry Chemical Manufacturing
ANZSIC 2006: 3323 - Industrial
and Agricultural Chemical Product Wholesaling
NACE 2002: 5155 - Wholesale
of chemical products
NAICS 2002: 4246 - Chemical
and Allied Products Merchant Wholesalers
UK SIC 2003: 5155 - Wholesale
of chemical products
US SIC 1987: 5169 - Chemicals
and Allied Products, Not Elsewhere Classified
Key Executives
|
Name |
Title |
|
Justus Dehio |
Managing director |
|
Frank Krause |
Managing director |
|
Philipp Titulski |
Managing director |
Registered No.(DEU): 4750AH
1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7190468
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.6969855
Corporate Overview
Location
Bultek 5
Siek, 22962
Germany
Tel: +49 (0) 4107 87780
Fax: +49 (0) 4107 8778100
Sales EUR(mil): 11.9
Assets EUR(mil): 4.9
Employees: 25
Fiscal Year End: 31-Dec-2009
Industry: Chemical
Manufacturing
Incorporation Date: 29-Oct-1987
Company Type: Private
Subsidiary
Quoted Status: Not
Quoted
Registered No.(DEU): 4750AH
Managing director: Justus
Dehio
Contents
· Industry Codes
· Business Description
· Financial Data
· Subsidiaries
· Key Corporate Relationships
Industry Codes
ANZSIC 2006 Codes:
3323 - Industrial and Agricultural Chemical Product Wholesaling
6240 - Financial Asset Investing
5309 - Other Warehousing and Storage Services
NACE 2002 Codes:
5155 - Wholesale of chemical products
6523 - Other financial intermediation not elsewhere classified
6312 - Storage and warehousing
NAICS 2002 Codes:
5259 - Other Investment Pools and Funds
4246 - Chemical and Allied Products Merchant Wholesalers
493 - Warehousing and Storage
US SIC 1987:
5169 - Chemicals and Allied Products, Not Elsewhere Classified
67 - Holding and Other Investment Offices
4225 - General Warehousing and Storage
UK SIC 2003:
6523 - Other financial intermediation not elsewhere classified
6312 - Storage and warehousing
5155 - Wholesale of chemical products
Business
Description
TRANSO - PHARM
HANDELS - GMBH is primarily engaged in wholesale of industrial chemicals
(aniline, printing ink, essential oils, industrial gases, chemical glues,
colouring matter, synthetic resin, methanol, paraffin, scents and flavourings,
soda, industrial salt, acids and sulphur, starch derivatives, etc.); wholesale
of fertilisers and agro-chemical products; wholesale of plastic materials in
primary forms; and wholesale of rubber.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Corporate
Family |
Corporate
Structure News: |
|
|
|
|
TRANSO - PHARM
HANDELS - GMBH |
|
|
|
|
|
|
|
|
Company Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Parent |
Siek, Schleswig-Holstein |
Germany |
Commercial Banks |
30.5 |
|
|
|
|
Subsidiary |
Siek, Schleswig-Holstein |
Germany |
Chemical Manufacturing |
16.5 |
25 |
|
|
|
Subsidiary |
Siek, Schleswig-Holstein |
Germany |
Chemical Manufacturing |
10.0 |
2 |
|
Executive report
|
Executives |
|
|
|
|
|||
|
Managing director |
Managing Director |
|
|||
|
Managing director |
Managing Director |
|
|||
|
Managing director |
Managing Director |
|
Annual Profit & Loss
|
|
31-Dec-2009 |
31-Dec-2008 |
31-Dec-2007 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate
(Period Average) |
0.719047 |
0.683679 |
0.730637 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Total income |
16.5 |
17.7 |
- |
|
Net sales |
16.5 |
17.7 |
- |
|
Other operating income |
1.1 |
0.9 |
- |
|
Cost of goods sold |
13.9 |
14.6 |
- |
|
Cost of raw materials |
13.9 |
14.6 |
- |
|
Taxes and social security costs |
- |
0.3 |
- |
|
Total payroll costs |
1.9 |
1.8 |
- |
|
Fixed asset depreciation and amortisation |
0.1 |
0.1 |
- |
|
Other operating costs |
2.6 |
2.7 |
- |
|
Net operating income |
0.4 |
0.9 |
- |
|
Other income |
0.5 |
0.3 |
- |
|
Interest payable on loans |
0.3 |
0.3 |
- |
|
Total expenses |
-0.3 |
0.0 |
- |
|
Profit before tax |
0.7 |
0.9 |
- |
|
Provisions |
0.7 |
0.7 |
0.5 |
|
Extraordinary expenses |
0.1 |
0.7 |
- |
|
Extraordinary result |
-0.1 |
-0.7 |
- |
|
Other taxes |
- |
0.0 |
- |
|
Total taxation |
0.0 |
0.0 |
- |
|
Net profit |
0.5 |
0.3 |
- |
Annual Balance
Sheet
Financials in: USD (mil)
|
|
31-Dec-2009 |
31-Dec-2008 |
31-Dec-2007 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.696986 |
0.719399 |
0.683971 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
0.6 |
0.6 |
0.6 |
|
Profits for the year |
0.4 |
0.3 |
0.0 |
|
Profit brought forward from previous year(s) |
-0.1 |
0.0 |
-0.1 |
|
Total
stockholders equity |
1.0 |
0.8 |
0.6 |
|
Deferred taxation |
0.0 |
0.4 |
- |
|
Other provisions |
0.2 |
0.2 |
- |
|
Provision for pensions |
0.5 |
- |
- |
|
Provisions and allowances |
0.7 |
0.7 |
0.5 |
|
Trade creditors |
3.3 |
2.4 |
- |
|
Advances received |
0.0 |
0.0 |
- |
|
Other loans |
0.0 |
0.1 |
- |
|
Taxation and social security |
0.0 |
0.1 |
- |
|
Due to group companies |
2.0 |
2.3 |
- |
|
Total current
liabilities |
5.3 |
4.9 |
6.1 |
|
Total liabilities
(including net worth) |
7.1 |
6.4 |
7.3 |
|
Patents |
0.0 |
- |
- |
|
Goodwill |
- |
0.0 |
- |
|
Intangibles |
0.0 |
0.0 |
0.0 |
|
Total tangible
fixed assets |
0.3 |
0.3 |
0.3 |
|
Long-term investments |
0.1 |
0.1 |
- |
|
Other financial assets |
- |
0.1 |
- |
|
Shares held in associated companies |
0.0 |
0.0 |
- |
|
Total financial
assets |
0.2 |
0.3 |
0.2 |
|
Total
non-current assets |
0.5 |
0.5 |
0.5 |
|
Finished goods |
1.3 |
1.8 |
- |
|
Net stocks and work in progress |
1.3 |
1.8 |
1.6 |
|
Trade debtors |
4.4 |
3.5 |
- |
|
Other receivables |
0.7 |
0.3 |
- |
|
Total
receivables |
5.2 |
4.0 |
5.1 |
|
Owing from associated companies |
0.1 |
0.2 |
- |
|
Cash and liquid assets |
0.0 |
0.0 |
0.0 |
|
Total current
assets |
6.6 |
5.8 |
6.7 |
|
Prepaid expenses and deferred costs |
0.0 |
0.1 |
0.1 |
|
Total assets |
7.1 |
6.4 |
7.3 |
Annual Ratios
Financials in: USD (mil)
|
|
31-Dec-2009 |
31-Dec-2008 |
31-Dec-2007 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.696986 |
0.719399 |
0.683971 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
12.28 |
11.81 |
10.98 |
|
Acid test ratio |
9.83 |
8.19 |
8.40 |
|
Total liabilities to net worth |
0.55% |
0.60% |
0.99% |
|
Net worth to total assets |
0.01% |
0.01% |
0.01% |
|
Current liabilities to net worth |
0.55% |
0.60% |
0.99% |
|
Current liabilities to stock |
0.41% |
0.28% |
0.39% |
|
Fixed assets to net worth |
0.05% |
0.07% |
0.08% |
|
Collection period |
949.00 |
766.00 |
- |
|
Stock turnover rate |
0.77 |
1.06 |
- |
|
Profit margin |
0.00% |
0.00% |
- |
|
Return on assets |
0.01% |
0.01% |
- |
|
Shareholders' return |
0.05% |
0.03% |
- |
|
Net worth |
1.0 |
0.8 |
0.6 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.67 |
|
UK Pound |
1 |
Rs.82.53 |
|
Euro |
1 |
Rs.69.13 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.